Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
The 29th British Oncology Pharmacy Association Annual (BOPA) Conference brings together oncology pharmacy professionals from across the UK for three days of learning, discussion and networking. The programme includes expert presentations, clinical updates, research-focused sessions and best practice discussions relevant to oncology pharmacy practice.
Programme highlights
Sessions will explore current and emerging issues in cancer pharmacy, including the role of cancer pharmacy in the 10-year cancer plan, genomics, the evolving role of pharmacy technicians in oncology and updates relevant to SACT practice.
The programme also includes haematology-focused content, including care of inpatient haematology, ATMP service set-up, Myeloma UK research priorities and a session on rapid progress in antibody-drug conjugates and bispecifics.
Who it is for
Sessions are designed to support a range of experience levels, from those newer to oncology pharmacy through to advanced practitioners. The event also offers an opportunity to connect with colleagues, share approaches from different services and stay up to date with developments across cancer treatment and pharmacy practice.